Urine real-time polymerase chain reaction detection for children virus pneumonia with acute human cytomegalovirus infection

BMC Infectious Diseases

Lin Zou¹  Zhou Fu¹  Enmei Liu¹  Bin Peng²  Junjie Tan¹  Zhaojian Yuan¹  Xinbin Wang¹  Rong Zhang¹  Xiaoyan He¹  Shi Tang¹  Penghui Zhang¹  Zhidai Liu¹ 

[1] Key Laboratory of Pediatrics in Chongqing, Children’s Hospital, Chongqing Medical University, Chongqing, China;Department of Health Statistics, School of Public Health, Chongqing Medical University, Yuzhong District, Chongqing, China

关键词: pp65 gene;    Urine sample;    Pneumonia;    Children;    Human cytomegalovirus;   

Others  :  1131253
DOI  :  10.1186/1471-2334-14-245

 received in 2013-11-08, accepted in 2014-04-28,  发布年份 2014

【 摘 要 】

Background

Human cytomegalovirus (HCMV) is an important pathogen of viral pneumonia in children. The diagnosis of acute HCMV infection is complicated and difficult.

Methods

Clinical and laboratory data of 6063 hospitalized children with respiratory infection and 509 with respiratory virus infection alone were retrospectively analyzed. Urine and respiratory specimens of 186 hospitalized children with pneumonia were also prospectively collected. Real-time polymerase chain reaction (PCR) and a chemiluminescent assay were used to detect HCMV DNA copy number, the pp65 gene, and HCMV IgM.

Results

The patients with respiratory virus infection alone and those with pulmonary HCMV infection (n = 422) were mostly children aged <6 months old (82.91%, 422/509). The accuracy of urine HCMV DNA (82.32%) was higher than that of HCMV IgM (67.78%), indicating that PCR of urine samples is suitable for determining pediatric acute pulmonary HCMV infection. There was no significant difference in detecting HCMV DNA or the pp65 gene between urinary and respiratory specimens (P > 0.05) in 186 pediatric pneumonia cases. The accuracy of the pp65 gene measured in urine for determining acute pulmonary HCMV infection was the highest (93.01%).

Conclusions

Our study shows a novel method for investigating acute pulmonary HCMV infection in children by using real-time PCR and non-invasive samples. This study also highlights the superiority and potential use of the pp65 gene as an important target for the diagnosis of acute pulmonary HCMV infection.

【 授权许可】

   
2014 Liu et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

【 参考文献 】

• [1]DeFrances CJ, Lucas CA, Buie VC, Golosinskiy A: National Hospital Discharge Survey. Natl Health Stat Report 2006, 2008(5):1-20.
• [2]Black RE, Bryce J, Caulfield L, Walker CF, Johnson H, Kalter H, Katz J, Liu L, Walker N, Bassani D, Jha P, Bhutta Z, Eisele T, Campbell H, Rudan I, Theodoratou E, Cousens S, Filippi V, Ezzati M, Lanata C, Lawn J, Peterson H, Steketee R, Bahl R, Boerma T, Cherian T, Fontaine O, Gore F, Hutubessy R, Martines J, et al.: Global, regional, and national causes of child mortality in 2008: a systematic analysis. Lancet 2010, 375(9730):1969-1987.
• [3]Yurochko AD, Huang ES: Immunological methods for the detection of human cytomegalovirus. Methods Mol Med 2000, 33:1-19.
• [4]Lazzarotto T, Guerra B, Lanari M, Gabrielli L, Landini MP: New advances in the diagnosis of congenital cytomegalovirus infection. J Clin Virol 2008, 41:192-197.
• [5]Revello MG, Gerna G: Diagnosis and management of human cytomegalovirus infection in the mother, fetus, and newborn infant. Clin Microbiol Rev 2002, 15(4):680-715.
• [6]Emery VC: CMV infected or not CMV infected: that is the question. Eur J Immunol 2013, 43(4):886-888.
• [7]Jang HJ, Kim AS, Hwang JB: Cytomegalovirus-associated esophageal ulcer in an immunocompetent infant: when should ganciclovir be administered? Korean J Pediatr 2012, 55(12):491-493.
• [8]Ozbek SM, Ozbek A, Yavuz MS: Detection of human cytomegalovirus and Epstein-Barr Virus in symptomatic and asymptomatic apical periodontitis lesions by real-time PCR. Med Oral Patol Oral Cir Bucal 2013, 18(5):e811-e816.
• [9]Tomtishen III: Human cytomegalovirus tegument proteins (pp65, pp71, pp150, pp28). Virol J 2012, 9-22. doi:10.1186/1743-422X-9-22.
• [10]Schmolke S, Kern HF, Drescher P, Jahn G, Plachter B: The dominant phosphoprotein pp 65 (UL83) of human cytomegalovirus is dis-pensable for growth in cell culture. J Virol 1995, 69(10):5959-5968.
• [11]Arnon TI, Achdout H, Levi O, Markel G, Saleh N, Katz G, Gazit R, Gonen-Gross T, Hanna J, Nahari E, Porgador A, Honigman A, Plachter B, Mevorach D, Wolf DG, Mandelboim O: Inhibition of the NKp30 activating receptor by pp 65 of human cytomegalovirus. Nat Immunol 2005, 6(5):515-523.
• [12]Boeckh M, Stevens-Ayers T, Bowden RA: Cytomegalovirus pp 65 Antigenemia after Autologous Marrow and Peripheral Blood Stem Cell Transplantation. J Infect Dis 1996, 174(5):907-912.
• [13]Rha B, Redden D, Benfield M, Lakeman F, Whitley RJ, Shimamura M: Correlation and clinical utility of pp 65 antigenemia and quantitative polymerase chain reaction assays for detection of cytomegalovirus in pediatric renal transplant patients. Pediatr Transplant 2012, 16(6):627-637.
• [14]Goussard P, Kling S, Gie RP, Nel ED, Heyns L, Rossouw GJ, Janson JT: CMV Pneumonia in HIV-Infected Ventilated Infants. Pediat Pulmonol 2010, 45(7):650-655.
• [15]Manteiga R, Martino R, Sureda A, Labeaga R, Brunet S, Sierra J, Rabella N: Cytomegalovirus pp 65 antigenemia-guided pre-emptive treatment with ganciclovir after allogeneic stem transplantation: a single-center experience. Bone Marrow Transplant 1998, 22(9):899-904.
• [16]Lutfiyya MN, Henley E, Chang LF, Reyburn SW: Diagnosis and treatment of community-acquired pneumonia. Am Fam Physician 2006, 73(3):442-450.
• [17]Pietras W, Chaber R, Pela H, Trybucka K, Chybicka A: The recovery of immune system parameters in children following lymphoblastic leukemia therapy - preliminary report. Adv Clin Exp Med 2014, 23(1):97-102.
• [18]Ljungman P, Griffiths P, Paya C: Definitions of cytomegalovirus infection and disease in transplant recipients. Clin Infect Dis 2002, 34(8):1094-1097.
• [19]Zhang S, Zhou YH, Li L, Hu Y: Monitoring human cytomegalovirus infection with nested PCR: comparison of positive rates in plasma and leukocytes and with quantitative PCR. Virol J 2010, 7:73. BioMed Central Full Text
• [20]Quinn FA: Bulk Reagent Random-Access Analyzer: Architech i2000. The Immunoassay Handbook 2nd edition. 2001, 363-367.
• [21]Paixão P, Almeida S, Videira PA, Ligeiro D, Marques T: Screening of congenital cytomegalovirus infection by real-time PCR in urine pools. Eur J Pediatr 2012, 171(1):125-129.
• [22]Vogel MN, Brodoefel H, Hierl T, Beck R, Bethge WA, Claussen CD, Horger MS: Differences and similarities of cytomegalovirus and pneumocystis pneumonia in HIV-negative immunocompromised patients thin section CT morphology in the early phase of the disease. Br J Radiol 2007, 80(955):516-523.
• [23]Balasubramanian S, Janakiraman L, Ganesh R, Deenadayalan M, Naidu RK: Interstitial lung disease in infancy. Indian J Pediatr 2007, 74(7):637-639.
• [24]Xiao YM, Hu ZH: Differences of clinical manifestations from cytomegalovirus infection in children of various age groups. Zhongguo Dang Dai Er Ke Za Zhi 2010, 12(1):21-23. Article in Chinese
• [25]Buffone GJ, Frost A, Samo T, Demmler GJ, Cagle PT, Lawrence EC: The diagnosis of CMV pneumonitis in lung and heart/lung transplant recipients by PCR compared with traditional laboratory criteria. Transplantation 1993, 56(2):342-347.
• [26]Gandhoke I, Aggarwal R, Hussain SA, Pasha ST, Sethi P, Thakur S, Lal S, Khare S: Congenital CMV infection; diagnosis in symptomatic infants. Indian J Med Microbiol 2009, 27(3):222-225.
• [27]Schrier RD, Rice GP, Oldstone MB: Suppression of natural killer cell activity and T cell proliferation by fresh isolates of human cytomegalovirus. J Infect Dis 1986, 153(6):1084-1091.